Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance Surveillance

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab060Source: DataRank Database

Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance Surveillance is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.37)OA: bronzeTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Gina Faraci ORCID,Gary Murphy ORCID,Christopher D. Pilcher,Michael P. Busch ORCID,Ha Youn Lee ORCID

Live enrichment

PubMed:33517458 OpenAlex:https://openalex.org/W3128721251

National Institutes of Health

Grant: R01-AI095066

Bill & Melinda Gates Foundation

Grant: OPP1017716

Bill & Melinda Gates Foundation

Grant: OPP1062806

Bill & Melinda Gates Foundation

Grant: OPP1115799

NIAID NIH HHS

Grant: R01 AI095066

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/jid/article-pdf/224/6/1048/40406152/jiab060.pdf

publisherhttps://academic.oup.com/jid/article-pdf/224/6/1048/40406152/jiab060.pdf

publisherhttp://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiab060/37062942/jiab060.pdf

publisherhttp://academic.oup.com/jid/article-pdf/224/6/1048/40406152/jiab060.pdf

journalhttps://doi.org/10.1093/infdis/jiab060

Fields of Study

HIV/AIDS drug development and treatmentHIV Research and TreatmentGenomics and Phylogenetic StudiesAnti-HIV AgentsCross-Sectional StudiesDrug Resistance, ViralGenotypeHIV InfectionsHIV-1HumansIncidenceMutationRNA, Viralpol Gene Products, Human Immunodeficiency Virus

MeSH Terms

Cross-Sectional StudiesGenotypeHumansMutationRNA, ViralHIV-1HIV InfectionsIncidenceAnti-HIV AgentsDrug Resistance, Viralpol Gene Products, Human Immunodeficiency Virus

Keywords

Drug resistanceVirologyIncidence (geometry)Human immunodeficiency virus (HIV)VirusBiologyPre-exposure prophylaxisMedicineGeneticsMen who have sex with menDrug resistance mutationsGenomic surveillanceHIVIncidence

Sustainable Development Goals

SDG 0: Good health and well-being